Kaitlyn Melanie Arsenault Skye Bioscience, Inc. (SKYE) insider trading activity

SKYE Quotes by TradingView

Kaitlyn Melanie Arsenault is Chief Financial Officer of Skye Bioscience, Inc.. Currently has a direct ownership of 210,738 shares of SKYE, which is worth approximately $1.22 Million. The most recent transaction as insider was on Feb 29, 2024, when has been sold 25,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 211K
0% 3M change
13.46% 12M change
Total Value Held $1.22 Million

Kaitlyn Melanie Arsenault Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 29 2024
BUY
Grant, award, or other acquisition
-
25,000 Added 10.6%
210,738 Common Stock
Nov 06 2023
BUY
Grant, award, or other acquisition
-
128,209 Added 40.84%
185,738 Common Stock
Aug 25 2023
BUY
Grant, award, or other acquisition
-
13,382,118 Added 48.2%
14,382,118 Common Stock
Dec 14 2021
BUY
Grant, award, or other acquisition
-
1,000,000 Added 50.0%
1,000,000 Common Stock
KMA

Kaitlyn Melanie Arsenault

Chief Financial Officer
San Diego, CA

Track Institutional and Insider Activities on SKYE

Follow Skye Bioscience, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells SKYE shares.

Notify only if

Insider Trading

Get notified when an Skye Bioscience, Inc. insider buys or sells SKYE shares.

Notify only if

News

Receive news related to Skye Bioscience, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on SKYE